XTX Technology recently submitted its listing application to the Hong Kong Stock Exchange. According to CIC, by 2024 revenue, the company ranked sixth among global code-type flash memory chip fabless companies with a 3.7% market share. The prospectus shows that the company's revenue was RMB 442 million with a net loss of RMB 37.136 million in 2024, but achieved a profit turnaround in the first nine months of 2025.
BioRay Biopharmaceutical recently submitted its listing application to the Hong Kong Stock Exchange. According to Frost & Sullivan, the company has ranked first among Chinese pharmaceutical companies by autoimmune disease biologics revenue for two consecutive years since 2023. The prospectus shows it recorded revenue of RMB 1.623 billion and net profit of RMB 91 million in 2024, with a gross margin of 79.2%.
On January 6, 2026, Deshi Bio re-submitted its listing application to HKEX with China Renaissance International as the sole sponsor, less than 8 days after the expiration of its initial prospectus in June 2025, aiming to become the first stock of AI chromosome diagnosis. As a national high-tech enterprise, its core product AI AutoVision® is China’s first AI chromosome diagnosis system certified as a Class III Innovative Medical Device by NMPA, currently under listing registration approval, and ranked first in China with a 30.6% market share in 2024.
Zhongan InfoTech recently filed a listing application with the Hong Kong Stock Exchange. According to a Frost & Sullivan report, the company ranks as China's fourth-largest enterprise-grade AI solutions provider equipped with vertical large model capabilities by 2024 revenue. The prospectus shows the company achieved 2024 revenue of RMB 309 million and net profit of RMB 33.231 million, representing significant growth. Its business core centers on intelligent marketing and operation management solutions, and it has built a capability system covering over 800 AI agents.
RelyEZ Energy Storage Technology Co., Ltd. officially submitted its main board listing application to the Hong Kong Stock Exchange on January 12, with CMB International acting as the sole sponsor. The company is a global provider of integrated energy storage system solutions and ranked first globally in newly added independent energy storage capacity in the first three quarters of 2025 among providers of full lifecycle energy storage asset solutions.
HKEX 2025 IPOs: HK$285B, #1 globally. 18C tech firms led. NewTimeSpace AI converts hard-tech metrics to value profiles, bridging gaps. NTS enables instant creation & global distribution.
Standard Robots filed a prospectus with the Hong Kong Stock Exchange again, with CITIC Securities and Guotai Junan International as joint sponsors. According to China Insights Consultancy, Standard Robots ranked among China's four major industrial intelligent mobile robot solution providers by sales volume in 2024. For the first nine months of 2025, revenue was RMB 188 million, up 19.7% year-over-year, while the loss for the period was RMB 163 million, representing an expansion compared to the same period last year.
New Shicoh Motor recently filed a listing application with the Hong Kong Stock Exchange, with CICC and Huatai International as joint sponsors. According to a Frost & Sullivan report, the company is China's largest optical image stabilization imaging motor supplier by 2024 revenue, holding a 20.1% market share. The prospectus shows the company achieved 2024 revenue of RMB 1.565 billion and swung to profitability with a net profit of RMB 105 million.
Hangzhou Diagens Biotechnology Co., Ltd. once again submitted an application for listing to the Hong Kong Stock Exchange on January 6. Relying on the world's largest parameter iMedImageTM medical imaging large model, the company firmly ranks as the leader in China's chromosome karyotype analysis market with a 30.6% market share.
Leadrive Technology recently filed a prospectus with the Hong Kong Stock Exchange for a Main Board listing, with CITIC Securities and Haitong International as joint sponsors. According to Frost & Sullivan, by installed capacity in the first three quarters of 2025, the company's motor controllers ranked eighth, dual-motor controllers ranked third; main drive power bricks ranked second, and power bricks for dual-motor controllers ranked first.
The public offering of MiniMax (00100.HK) is scheduled to close at 12:00 noon today (January 6). Data shows that the public offering tranche has recorded an over-subscription rate of around 1,350.75 times, with margin financing funds reaching approximately HK$283.143 billion. The company is expected to be listed on the Main Board of the Hong Kong Stock Exchange on January 9.
Mandi Inc. is required to supplement explanations on matters including the compliance of round-trip investment procedures, the basis for controlling shareholder identification, the full disclosure of the trustee controller structure and beneficiaries, data security management, and the compliance of domestic businesses with foreign investment access rules in its overseas listing filing. Lawyers shall conduct penetrating verification on the above matters and issue legal opinions.
Shanghai Sunmi Technology Group has obtained CSRC filing approval for its proposed Hong Kong IPO of up to 46,000,000 shares and conversion of 261,415,724 domestic shares held by 13 shareholders into H-shares for circulation. The filing is valid for 12 months, requires reporting of material events and post-listing details within 15 working days, and does not represent CSRC's endorsement of investment value or accuracy of materials.
Beijing Roborock Technology has obtained CSRC filing approval for its proposed Hong Kong IPO of up to 33,108,000 shares. The filing is valid for 12 months, requires reporting of material events and post-listing details within 15 working days, and does not represent CSRC's endorsement of investment value or accuracy of materials.
Hangzhou DESH Biological Technology has received CSRC filing approval for its proposed Hong Kong IPO of up to 31,004,000 shares and conversion of 80,880,000 domestic shares held by 27 shareholders into H-shares for circulation. The filing is valid for 12 months, requires reporting of material events and post-listing details within 15 working days, and does not represent CSRC's endorsement of investment value or accuracy of materials.
UISEE Technology (Beijing) has obtained CSRC filing approval for its proposed Hong Kong IPO of up to 18,914,150 shares and conversion of 112,264,250 domestic shares held by 41 shareholders into H-shares for circulation. The filing is valid for 12 months, requires reporting of material events and post-listing details within 15 working days, and does not represent CSRC's endorsement of investment value or accuracy of materials.
